Mallinckrodt plc Reports Fiscal 2015 Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Leerink Partners Upgrades Mallinckrodt plc (MNK) to Outperform on Valuation
August 6, 2015 2:40 PM EDTLeerink Partners upgraded Mallinckrodt plc (NYSE: MNK) from Market Perform to Outperform with a price target of $112. Analyst Jason M. Gerberry tied the upgrade to valuation.
"We are upgrading MNK on valuation as the stocks recent plummet post F3Q has created a buying opportunity, in our... More
Piper Jaffray Cuts Price Target on Mallinckrodt (MNK) to $140 Following 3Q EPS Beat
August 5, 2015 9:40 AM EDTPiper Jaffray reiterated an Overweight rating on Mallinckrodt plc (NYSE: MNK), and cut the price target to $140.00 (from $150.00), following 3Q15 results. Mallinckrodt reported 3Q15 diluted EPS of $2.05, ahead of the Street estimate of $1.83. Revenues of $965M missed the Street's $986M estimate.
Analyst David Amsellem commented, "Mallinckrodt reported fiscal... More
Mallinckrodt (MNK) PT, Estimates Lowered at Leerink Partners Following Mixed Q3
August 5, 2015 7:48 AM EDTLeerink Partners analyst Jason Gerberry lowered estimates and his price target on Market Perform-rated Mallinckrodt plc (NYSE: MNK) to $112.00 (from $133.00) following mixed Q3 results that included a ~$20m miss on consensus due to weaker than expected Acthar (autoimmune disease) and oxycodone Gx... More
JPMorgan Downgrades Mallinckrodt plc (MNK) to Neutral
August 5, 2015 7:10 AM EDTJPMorgan downgraded Mallinckrodt plc (NYSE: MNK) from Overweight to Neutral with a price target of $120.00 (from $140.00).
For an analyst ratings summary and ratings history on Mallinckrodt plc click here. For more ratings news on Mallinckrodt plc click here.
Shares of Mallinckrodt plc closed at $106.73 yesterday.
... MoreMallinckrodt (MNK) Tops Q3 EPS by 23c
August 4, 2015 7:00 AM EDTMallinckrodt (NYSE: MNK) reported Q3 EPS of $2.05, $0.23 better than the analyst estimate of $1.82. Revenue for the quarter came in at $965.1 million versus the consensus estimate of $985.3 million.
"Mallinckrodt reported another solid quarter, with meaningful top- and bottom-line growth in our Specialty Brands segment. The revenue... More

